The philosophies of one age have become the absurdities of the next, and the foolishness of
yesterday has become the wisdom of tomorrow. dOsler Controversy being in no short …

The field of Barrett's esophagus has been flourishing with major advances in quality clinical
practices and technological innovations in both diagnosis and treatment. Gaps in the current …

The annual incidence of adenocarcinoma arising from Barrett's esophagus (BE) is
approximately 0.5%. Through a process of gradual transformation from low-grade dysplasia …

In the last 5–10 years, endoscopic ablative therapies have been gaining ground as
treatment for Barrett's esophagus associated with high-grade dysplasia and early cancer …

Background The management of high-grade dysplasia (HGD) in Barrett's oesophagus is a
controversial and challenging problem. Methods An up-to-date review of the literature has …

Barrett's esophagus with high-grade dysplasia is a well-known risk factor for the
development of esophageal adenocarcinoma, which has become the predominant form of …

New mucosal ablative techniques that can be used in the esophagus have emerged over
the past two decades. These techniques have been developed primarily to treat the …

Current practices for the management of Barrett's esophagus (BE) vary across Europe, as
several national European guidelines exist. This Position Statement from the European …

Interventions for Barrett's oesophagus and early cancer | British Journal of Surgery | Oxford
Academic Skip to Main Content Advertisement intended for healthcare professionals Oxford …

The rising incidence of esophageal adenocarcinoma has focused attention on the only
known risk factor: Barrett's esophagus. Practice guidelines for the diagnosis, surveillance …